
Loading, please wait...

Loading, please wait...

Sleep quality in WLHIV is a critical but often overlooked aspect of comprehensive care for women living with HIV. While hormonal shifts during pregnancy and the postpartum period frequently cause sleep disruptions, recent evidence suggests that reproductive stage alone may not be the primary driver. The Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study investigated these patterns to understand what truly affects sleep health in this population.
The HOPE study analyzed 500 women across various stages, including those who were nulliparous, pregnant, or postpartum. Interestingly, the prevalence of poor sleep remained high across all groups, ranging from 44% to 54%. After adjusting for confounding variables, the researchers found no significant difference in sleep quality based on the reproductive stage itself. This finding shifts the clinical focus from biological life stages to more modifiable psychosocial factors.
Mental health conditions emerged as the strongest predictors of sleep disturbances. Specifically, women who screened positive for moderate to severe depression, anxiety, or post-traumatic stress disorder (PTSD) reported significantly higher rates of poor sleep. Additionally, high levels of perceived stress and housing instability were major contributors. Consequently, addressing these psychological and social stressors is essential for improving the quality of life for women living with HIV.
Clinicians should prioritize routine screenings for mental health disorders and social determinants of health. By identifying homelessness or severe anxiety early, providers can implement targeted interventions. Therefore, holistic care models that integrate mental health support with traditional HIV management may offer the best path to improving sleep outcomes. This approach is particularly relevant in high-burden settings where psychosocial support is often limited.
While postpartum and parous women show slightly higher rates of poor sleep, the HOPE study indicates that reproductive stage is not an independent driver after adjusting for factors like mental health and social stressors.
The main predictors include moderate to severe depression, anxiety, PTSD, high perceived stress, and homelessness. These psychosocial factors have a more substantial impact than hormonal or HIV-specific clinical markers.
Providers should regularly screen patients for mental health issues and social instability. Addressing these root causes through integrated care and psychosocial support is vital for improving sleep quality.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Al-Ani R et al. Sleep Quality by Reproductive Stage among Women Living with HIV in the United States Enrolled in the Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) Study. J Acquir Immune Defic Syndr. 2026 Apr 10. doi: 10.1097/QAI.0000000000003856. PMID: 41962148.
2. Ballerini A et al. Sleep Disorders Are Associated with Mental Health, Quality of Life and Stigma in an Italian Cohort of People Living with HIV. MDPI. 2025 Mar 23. doi: 10.3390/ijerph20042819.
3. Kumar S et al. Evaluation of depression, anxiety and insomnia in people living with HIV/AIDS in India. ResearchGate. 2023 Apr 06. Source: PGIMS Rohtak Study.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 500 women shows that poor sleep quality in WLHIV is common across all reproductive stages and is primarily driven by mental health and social str...
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today